Bank of America’s Bionano Genomics BNGO Stock Holding History

Bank of America’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-417	Closed	-$1.83M	–	8110
2021 Q2	$1.83M	Buy	+417	New	+$1.65M	﹤0.01%	4400

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of America's BNGO Position: Q1 2026 in Review

Bank of America sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 8,453 shares — an estimated $12.9K sold.

Bank of America first reported a position in BNGO in Q2 2019 and held it in 21 quarters. The position peaked at $2.52M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Bank of America reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
Bank of America sold 8,453 Bionano Genomics shares in Q1 2026, an estimated $12.9K.
Bank of America first reported a position in Bionano Genomics in Q2 2019 and held it in 21 quarters.
Bank of America's Bionano Genomics position peaked at $2.52M in Q2 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.